Shares of Axsome Therapeutics, Inc. (AXSM) are falling more than 10% Wednesday morning after the company priced its public offering of 3 million shares at $75 per share.
The company plans to use the proceeds of nearly $225 million from the offering to fund its clinical studies, to expand commercialization efforts, and for other general corporate purposes.
The offering is expected to close by June 30.
AXSM, currently at $75, has traded in the range of $35.16 - $91.29 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.